This website is for Israeli Healthcare Professionals only

AbbVie's Future Molecules in IBD

Lectures From The 16th Congress of ECCO Viewing Event

View Leading Experts Presentations

Watch Dr. Matti Waterman, Prof. Ariella Bar-Gil ShitritDr. Irit Avni Biron speak about new modes of action in IBD & AbbVie’s future molecules.

Duration 22:08

New molecules for IBD
Dr. Irit Avni Biron

Duration 22:57

AbbVie's future molecules in IBD 
Prof. Ariella Bar-Gil Shitrit

Duration 22:24

New MOA & AbbVie’s pipeline in IBD
Dr. Matti Waterman


AbbVie’s Symposia Agenda

For ECCO registered attendees, the induction results of Risankizumab in CD and Upadacitinib in UC are available in the scientific program (oral presentations), and as part of Abbvie's symposia.

To view AbbVie’s symposia agenda click here

 

 

 

RISN-IL-00007-MC